Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$3.64 - $7.78 $43,341 - $92,636
-11,907 Closed
0 $0
Q3 2021

Jun 21, 2023

BUY
$6.01 - $8.71 $71,561 - $103,709
11,907 New
11,907 $93,000
Q3 2021

Mar 30, 2023

BUY
$6.01 - $8.71 $15,734 - $22,802
2,618 Added 28.18%
11,907 $93,000
Q3 2021

Nov 15, 2021

BUY
$6.01 - $8.71 $71,561 - $103,709
11,907 New
11,907 $94,000
Q2 2021

Aug 16, 2021

SELL
$6.02 - $9.64 $54 - $86
-9 Closed
0 $0
Q1 2021

Jun 26, 2023

BUY
$9.17 - $14.8 $85,180 - $137,477
9,289 New
9,289 $87.4 Million
Q1 2021

Mar 30, 2023

SELL
$9.17 - $14.8 $15,625 - $25,219
-1,704 Reduced 15.5%
9,289 $87,000
Q1 2021

May 14, 2021

SELL
$9.17 - $14.8 $100,723 - $162,563
-10,984 Reduced 99.92%
9 $87,000
Q4 2020

Jun 22, 2023

BUY
$8.92 - $13.29 $98,057 - $146,096
10,993 New
10,993 $124,000
Q3 2020

Jun 26, 2023

BUY
$9.94 - $16.59 $109,270 - $182,373
10,993 New
10,993 $117,000
Q2 2020

Jun 26, 2023

BUY
$12.07 - $19.34 $132,685 - $212,604
10,993 New
10,993 $166,000
Q2 2020

Mar 30, 2023

BUY
$12.07 - $19.34 $29,136 - $46,686
2,414 Added 28.14%
10,993 $166,000
Q2 2020

Aug 14, 2020

BUY
$12.07 - $19.34 $29,136 - $46,686
2,414 Added 28.14%
10,993 $167,000
Q1 2020

Jul 12, 2023

BUY
$12.5 - $22.04 $107,237 - $189,081
8,579 New
8,579 $133,000
Q1 2020

Mar 30, 2023

SELL
$12.5 - $22.04 $1,162 - $2,049
-93 Reduced 1.07%
8,579 $133,000
Q1 2020

May 15, 2020

SELL
$12.5 - $22.04 $1,162 - $2,049
-93 Reduced 1.07%
8,579 $133,000
Q4 2019

Jul 12, 2023

BUY
$11.42 - $22.19 $99,034 - $192,431
8,672 New
8,672 $179,000
Q3 2019

Jul 12, 2023

BUY
$14.74 - $22.28 $127,825 - $193,212
8,672 New
8,672 $156,000
Q3 2019

Mar 30, 2023

BUY
$14.74 - $22.28 $36,820 - $55,655
2,498 Added 40.46%
8,672 $156,000
Q3 2019

Nov 14, 2019

BUY
$14.74 - $22.28 $36,820 - $55,655
2,498 Added 40.46%
8,672 $157,000
Q2 2019

Jul 12, 2023

BUY
$18.35 - $30.34 $122,211 - $202,064
6,660 New
6,660 $130,000
Q1 2019

Jul 13, 2023

BUY
$19.76 - $29.57 $121,998 - $182,565
6,174 New
6,174 $171,000
Q1 2019

Mar 30, 2023

BUY
$19.76 - $29.57 $121,998 - $182,565
6,174 New
6,174 $171,000
Q1 2019

May 16, 2019

SELL
$19.76 - $29.57 $424,247 - $634,867
-21,470 Reduced 77.67%
6,174 $171,000
Q1 2019

May 15, 2019

BUY
$19.76 - $29.57 $424,247 - $634,867
21,470 Added 347.75%
27,644 $1.95 Million
Q4 2018

Jul 13, 2023

BUY
$18.39 - $26.3 $113,539 - $162,376
6,174 New
6,174 $138,000
Q4 2018

Feb 14, 2019

BUY
$18.39 - $26.3 $113,539 - $162,376
6,174 New
6,174 $138,000

Others Institutions Holding FIXX

About Homology Medicines, Inc.


  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.